5-LIO(ME-3,2-HOPO)

A systematic electronic structure analysis was conducted for M(L)n molecular electrides and their corresponding alkalide units M(L)n@M′ (M/M′ = Na, K; L = Tren, Azacryptand, TriPip222; n = 1, 2). All complexes belong to the “superalkali” category due to their low ionization potentials. The saturated molecular electrides display M+(L)n− form with a greatly diffuse quasispherical electron cloud. They were identified as “superatoms” considering the contours of populating atomic‐type molecular orbitals. The observed superatomic Aufbau order of M(Tren)2 is 1S, 1P, 1D, 1F, 2S, 2P, and 1G and it is consistent with those of M(Azacryptand) and M(TriPip222) up to the analyzed 1F level. Their excitation energies decrease gradually moving from M(Tren)2 to M(Azacryptand) and to M(TriPip222). The studied alkalide complexes carry [M(L)n]+@M′− ionic structure and their dissociation energies vary in the sequence of K(L)n@Na > Na(L)n@Na > K(L)n@K > Na(L)n@K. Similar to molecular electrides, the anions of alkalide units occupy electrons in diffuse Rydberg‐like orbitals. In this work, excited states of [M(L)n@M′]0/+/− and their trends are also analyzed.

Hypoxia activated Co(III) complexes as prodrugs may provide with a selective delivery of cytotoxic or antibacterial compounds. Whithin this field sixteen novel Co(III) ternary complexes with the general formula [Co(4N)(flav)](ClO₄)₂, where 4N = tris(2-aminoethyl)amine (tren) or tris(2-pyridylmethyl)amine (tpa) and flav = deprotonated form of differently substituted flavonols have been synthesized, characterized, and their cytotoxicity assayed under both normoxic and hypoxic conditions. Molecular structures of two free flavonols and seven complexes are also reported. In all the complexes the bioligands exhibited the expected (O,O) coordination mode and the complexes showed a slightly distorted octahedral geometry. Cyclic voltammetric studies revealed that both the substituents of the flavonoles and the type of 4N donor ligands had an impact on the reduction potential of the complex. The ones containing tren demonstrated significantly higher stability than the tpa analogues, making these former compounds promising candidates for the development of hypoxia-activated prodrug complexes. Tpa complexes showed higher activity against both selected human cancer cell lines (A549, A431) than their free ligand flavonols, indicating that the anticancer activity of the bioligand can be enhanced upon complexation. However, slight hypoxia-selectivity was found only for a tren complex (11) with moderate cytotoxicity.